4.3 Article

Potential Cost Savings by Switching from Subcutaneous to Intralymphatic Insect Venom Immunotherapy

Related references

Note: Only part of the references are listed.
Article Allergy

Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A 3-year randomized placebo-controlled trial

Soren Helbo Skaarup et al.

Summary: ILIT can significantly reduce grass pollen allergy symptoms and use of rescue medication, particularly in the first season after treatment. A booster injection one year later had no additional effect. Repeated measures of IgE and IgG4 in the ILIT groups showed significant between-group differences and within-group changes.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Biotechnology & Applied Microbiology

Venom immunotherapy in indolent systemic mastocytosis with high serum tryptase level

Ali Selcuk et al.

Summary: Mastocytosis is a rare group of disorders characterized by abnormal accumulation of mast cells, particularly in patients with systemic mastocytosis, who are at increased risk of severe anaphylaxis, often triggered by hymenoptera venom allergy. Immunotherapy is an effective and safe treatment option, but can lead to systemic side effects during up-dosing, making progression to maintenance challenging.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Otorhinolaryngology

Cost-effective Analysis of Subcutaneous vs Sublingual Immunotherapy From the Payor's Perspective

Frances Mei Hardin et al.

Summary: A study comparing the cost-effectiveness of SCIT and SLIT found that SLIT is more economically favorable for successful treatment outcomes and is the financially conscious option for patients with >40% adherence to therapy.

OTO OPEN (2021)

Article Allergy

Bee Venom Immunotherapy: Current Status and Future Directions

Abida Zahirovic et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)

Article Allergy

Intralymphatic immunotherapy for mountain cedar pollinosis A randomized, double-blind, placebo-controlled trial

Christopher P. Thompson et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2020)

Review Allergy

Intralymphatic Immunotherapy: Update and Unmet Needs

Gabriela Senti et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)

Letter Allergy

Intralymphatic Immunotherapy Alleviates Allergic Symptoms During Allergen Exposure in Daily Life

Sang Pyo Lee et al.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2018)

Article Allergy

Safety and efficacy of venom immunotherapy: a real life study

Agnieszka Kolaczek et al.

POSTEPY DERMATOLOGII I ALERGOLOGII (2017)

Letter Allergy

Dosing intervals in intralymphatic immunotherapy

A. Hjalmsdottir et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2016)

Letter Allergy

High adherence to hymenoptera venom subcutaneous immunotherapy over a 5-year follow-up: A real-life experience

Maria Beatrice Bilo et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2016)

Article Medicine, Research & Experimental

Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs

Cezmi A. Akdis et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Allergy

Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections

Gabriela Senti et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Review Biotechnology & Applied Microbiology

New routes for allergen immunotherapy

Pal Johansen et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)

Article Allergy

Diagnosis and Treatment of Bees and Wasp Venom Allergy

Bernhard Przybilla et al.

ALLERGO JOURNAL (2011)

Article Multidisciplinary Sciences

Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

Gabriela Senti et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)